Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Telomir Pharmaceuticals, Inc. Common Stock
Market Cap
$82.53M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$82.47M
Operating Margin
-8256.32%
TTM Avg
-7689.73%
3Y Avg
-8755.63%
5Y Avg
-8045.81%
Market Cap
$82.59M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-70860.78%
Market Cap
$82.29M
Operating Margin
-42.06%
TTM Avg
-31.00%
3Y Avg
-37.02%
5Y Avg
-45.87%
Market Cap
$81.22M
Operating Margin
-3242.47%
TTM Avg
-1621.23%
3Y Avg
-1058.13%
5Y Avg
-747.59%
Market Cap
$81.20M
Operating Margin
-408.41%
TTM Avg
-360.51%
3Y Avg
-288.53%
5Y Avg
-284.25%
Market Cap
$84.13M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$80.30M
Operating Margin
-5271.69%
TTM Avg
-2635.84%
3Y Avg
-2669.01%
5Y Avg
-3573.08%
Market Cap
$79.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $82.53M | 0.00% | 0.00% | 0.00% | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | -8256.32% | -7689.73% | -8755.63% | -8045.81% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $82.59M | 0.00% | 0.00% | 0.00% | -70860.78% |
| LENSAR Inc (LNSR)vs › | $82.29M | -42.06% | -31.00% | -37.02% | -45.87% |
| MediciNova, Inc. (MNOV)vs › | $81.22M | -3242.47% | -1621.23% | -1058.13% | -747.59% |
| Nutriband Inc. (NTRB)vs › | $81.20M | -408.41% | -360.51% | -288.53% | -284.25% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| Humacyte, Inc. (HUMA)vs › | $80.30M | -5271.69% | -2635.84% | -2669.01% | -3573.08% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.86M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
